Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06698679

The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer

Sponsor: Shengjing Hospital

View on ClinicalTrials.gov

Summary

This study investigates plasma metabolites to clarify the relationship between these metabolites and breast cancer, aiming to identify valuable biomarkers. Furthermore, by incorporating clinical information-such as cancer stage, type, treatment outcomes, and prognosis-into prospective studies, the research seeks to further examine the correlation between plasma metabolites, treatment efficacy, and prognosis.

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2024-11-15

Completion Date

2031-10-31

Last Updated

2024-11-21

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

No intervention

There is no intervention in this study. We will obtain blood from the recruited patients and assess the metabolites therein. This is an observational work.

Locations (1)

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China